Bibliographic Info
GuidelineWHO guidelines on hepatitis B and C testing.
Year of Publication2017
Issuing InstitutionWHO
Recommendation
Status
Maintained
Recommended in favor
Conditional
Certainty of evidence
Low
Monitoring for HBV treatment response and disease progression. In persons who do not yet meet the criteria for antiviral therapy: i.e. persons who have intermittently abnormal ALT levels or HBV DNA levels that fluctuate between 2000 IU/mL and 20 000 IU/mL (where HBV DNA testing is available) and in HIV coinfected persons
Also Featured In
This recommendation also appears in the following guidelines:
Originally Developed
Guideline
Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection
Year2015
InstitutionWorld Health Organization
Guideline
Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection.
Year2024
InstitutionWHO